Neil Desai, EXECUTIVE CHAIRMAN at Aadi Bioscience, Inc. (AADI), sold 40,000 shares at $2.31 ($91K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($91k) by EXECUTIVE CHAIRMAN under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.31 | 17,772 | $41K | 45.3% |
| 2 | $2.23 | 22,228 | $50K | 54.7% |
| Total | $2.27 avg | 40,000 | $91K | 100% |
| Filing → |
| AADI | SELL | 2024-07-02 | $57K | — | Filing → |
| AADI | SELL | 2024-06-05 | $72K | — | Filing → |
| AADI | SELL | 2024-05-01 | $77K | — | Filing → |